ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
127.128,06
-0,37%
S&P 500
6.013,13
-1,71%
US Dollar vs BRL
5,7324
0,00%
Bitcoin
95.526,00
-1,08%
Brent Oil
73,935
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. OptiNose Inc (OPTN)

  7. OptiNose Inc (OPTN) Notícias

OPTN

OptiNose (OPTN)

OptiNose Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OPTN
DataHoraFonteTítuloCódigoCompanhia
07/02/202513:58Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OPTNOptiNose Inc
15/01/202509:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
15/01/202509:00GlobeNewswire Inc.Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 MillionNASDAQ:OPTNOptiNose Inc
26/12/202409:00GlobeNewswire Inc.Optinose Announces 1-for-15 Reverse Stock SplitNASDAQ:OPTNOptiNose Inc
18/12/202418:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
17/12/202411:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
12/12/202412:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OPTNOptiNose Inc
02/12/202418:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPTNOptiNose Inc
02/12/202417:53GlobeNewswire Inc.Optinose to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:OPTNOptiNose Inc
12/11/202410:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPTNOptiNose Inc
12/11/202409:00GlobeNewswire Inc.Optinose Reports Third Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
05/11/202418:30GlobeNewswire Inc.Optinose Announces Reporting Date for Third Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
18/10/202415:52Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OPTNOptiNose Inc
16/10/202417:05GlobeNewswire Inc.Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OPTNOptiNose Inc
07/10/202419:39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
07/10/202417:59GlobeNewswire Inc.Optinose Appoints Terry Kohler as Chief Financial OfficerNASDAQ:OPTNOptiNose Inc
05/09/202410:00GlobeNewswire Inc.New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus SurgeryNASDAQ:OPTNOptiNose Inc
26/08/202410:00GlobeNewswire Inc.Optinose to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:OPTNOptiNose Inc
08/08/202408:00GlobeNewswire Inc.Optinose Reports Second Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
02/08/202409:30GlobeNewswire Inc.Optinose Announces Reporting Date for Second Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
27/06/202408:00GlobeNewswire Inc.Expanded Access to XHANCE with Addition to National Commercial FormulariesNASDAQ:OPTNOptiNose Inc
29/05/202416:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPTNOptiNose Inc
20/05/202415:33Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:OPTNOptiNose Inc
17/05/202413:00GlobeNewswire Inc.Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:OPTNOptiNose Inc
14/05/202408:00GlobeNewswire Inc.Optinose Reports First Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
10/05/202415:56GlobeNewswire Inc.Optinose Announces Reporting Date for First Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
09/05/202408:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPTNOptiNose Inc
09/05/202408:00GlobeNewswire Inc.Optinose Announces $55 Million Registered Direct OfferingNASDAQ:OPTNOptiNose Inc
25/04/202408:00GlobeNewswire Inc.Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 millionNASDAQ:OPTNOptiNose Inc
04/04/202417:01GlobeNewswire Inc.Optinose to Present at the Needham Virtual Healthcare ConferenceNASDAQ:OPTNOptiNose Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:OPTN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
FICT3
Fictor Alimentos ON
BOV
IDIV
Dividend
BOV
BRKM5
BRASKEM PNA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios